Trial intelligence / Profile preview

Propofol versus sevoflurane induction for prevention of perioperative respiratory adverse events in high-risk children

ACTRN12610000252011Phase 4Completed

Sponsor
Britta Regli-von Ungern
Start
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial comparing Intravenous propofol induction with Inhalational sevoflurane induction (2 arms). Primary endpoint: Incidence of perioperative respiratory complications. Started Aug 2010; status: completed.

02

Drugs

propofolsevoflurane

Beyond the preview

Go deeper on ACTRN12610000252011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000252011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call